Analysis of the fibroblast growth factor system reveals alterations in a mouse model of spinal muscular atrophy.
The monogenetic disease Spinal Muscular Atrophy (SMA) is characterized by a progressive loss of motoneurons leading to muscle weakness and atrophy due to severe reduction of the Survival of Motoneuron (SMN) protein. Several models of SMA show deficits in neurite outgrowth and maintenance of neuromus...
Main Authors: | Niko Hensel, Andreas Ratzka, Hella Brinkmann, Lars Klimaschewski, Claudia Grothe, Peter Claus |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3278439?pdf=render |
Similar Items
-
ERK and ROCK functionally interact in a signaling network that is compensationally upregulated in Spinal Muscular Atrophy
by: Niko Hensel, et al.
Published: (2017-12-01) -
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
by: Niko Hensel, et al.
Published: (2020-02-01) -
Investigations of Microtubule-associated Protein 2 Gene Expression in Spinal Muscular Atrophy
by: Gamze Bora, et al.
Published: (2019-06-01) -
The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy
by: Charlotte Spicer, et al.
Published: (2021-04-01) -
Nusinersen for spinal muscular atrophy
by: Claudia D. Wurster, et al.
Published: (2018-03-01)